SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001104659-23-063385
Filing Date
2023-05-23
Accepted
2023-05-23 06:49:01
Documents
10
Period of Report
2023-05-23

Document Format Files

Seq Description Document Type Size
1 PREM14A tm2316342-1_prem14a.htm PREM14A 2483974
2 EX-FILING FEES tm2316342d2_ex-filingfees.htm EX-FILING FEES 22112
3 GRAPHIC ft_centerviewpartners-bwlr.jpg GRAPHIC 45111
4 GRAPHIC hd_bankofamericaglobal-4clr.jpg GRAPHIC 65881
5 GRAPHIC lg_bankofamerica-4clr.jpg GRAPHIC 15827
6 GRAPHIC lg_centerviewpartners-bwlr.jpg GRAPHIC 17513
7 GRAPHIC px_ivericbiopg01-bw.jpg GRAPHIC 984822
8 GRAPHIC px_ivericbiopg02-bw.jpg GRAPHIC 876160
9 GRAPHIC sg_bofasecuritiesinc-bw.jpg GRAPHIC 17283
10 GRAPHIC sg_centerviewpartnersllc-4c.jpg GRAPHIC 21970
  Complete submission text file 0001104659-23-063385.txt   5069459
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-36080 | Film No.: 23946489
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences